Determination of 8-iso-prostaglandin F2α (8-iso-PGF2α) in human urine by ultra-performance liquid chromatography–tandem mass spectrometry
- 1 February 2014
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 947-948, 173-178
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Quantification of urinary 8‐iso‐prostaglandin F2αusing liquid chromatography–tandem mass spectrometry during cardiac valve surgeryJournal of Clinical Laboratory Analysis, 2010
- Generic Approach to Validation of Small-Molecule LC–MS/MS Biomarker AssaysBioanalysis, 2009
- Women and Smokers Have Elevated Urinary F2‐Isoprostane Metabolites: A Novel Extraction and LC–MS MethodologyLipids, 2008
- Quantitation of isoprostane isomers in human urine from smokers and nonsmokers by LC-MS/MSJournal of Lipid Research, 2007
- Control of matrix effects in the analysis of urinary F2-isoprostanes using novel multidimensional solid-phase extraction and LC-MS/MSJournal of Lipid Research, 2007
- HPLC–Atmospheric Pressure Chemical Ionization MS/MS for Quantification of 15-F2t-Isoprostane in Human Urine and PlasmaClinical Chemistry, 2007
- Quantifying F2-isoprostanes in umbilical cord blood of newborn by gas chromatography-mass spectrometryAnalytical Biochemistry, 2003
- Rapid and sensitive quantification of 8-isoprostaglandin F2α in human plasma and urine by liquid chromatography–electrospray ionization mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- Isoprostanes: Formation, Analysis and Use As Indices of Lipid Peroxidation in VivoJournal of Biological Chemistry, 1999
- Identification and Measurement of Endogenous β-Oxidation Metabolites of 8-epi-Prostaglandin F2αJournal of Biological Chemistry, 1999